Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2007-10-19

Clinical Trial Update: Study Evaluating the Efficacy and Safety of Etanercept [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating the efficacy and safety of etanercept for rheumatoid arthritis has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Etanercept (etanercept)

Snippet

Sponsor: Wyeth is now a wholly owned subsidiary of Pfizer | Conditions: Rheumatoid Arthritis | Phase 4 | Status: COMPLETED